AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 99 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.89 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $70,000 | -69.4% | 1,711 | -51.5% | 0.00% | – |
| Q4 2015 | $229,000 | -8.0% | 3,525 | 0.0% | 0.00% | – |
| Q3 2015 | $249,000 | -27.8% | 3,525 | +13.9% | 0.00% | -100.0% |
| Q2 2015 | $345,000 | +148.2% | 3,095 | +109.5% | 0.00% | – |
| Q1 2015 | $139,000 | -88.1% | 1,477 | -85.9% | 0.00% | -100.0% |
| Q4 2014 | $1,172,000 | -1.0% | 10,445 | -45.9% | 0.00% | 0.0% |
| Q3 2014 | $1,184,000 | +7.0% | 19,293 | -29.6% | 0.00% | 0.0% |
| Q2 2014 | $1,107,000 | +35.0% | 27,422 | +30.8% | 0.00% | +100.0% |
| Q1 2014 | $820,000 | – | 20,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |